Registry for high-dose radiation re-treatment in cancer
Part of Injuries & trauma clinical trials.
This study tracks patients receiving high-dose radiation therapy a second time (or more) to treat cancer that has come back or spread to a few spots. Researchers want to understand how well this approach works and what side effects patients experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are receiving high-dose radiation therapy targeting a recurrent (returned) cancer, new area of cancer, or a few spots of spread
- You can read and understand Danish, as questionnaires and patient information are in Danish
- You are expected to live at least 6 more months based on your age and overall health
- Your general health is strong enough to handle potentially serious, lasting side effects from radiation
- You have medical records from your previous radiation treatment(s), including dose plans or imaging
- You can attend all your radiation appointments and agree to follow-up visits (in person, by video, or by phone)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a second course of radiation to the chest (called retreatment) can control lung cancer that has come back or a new cancer that started there. People who have already had radiation to their chest and are healthy enough for more may be eligible.
This study looks at whether re-treating prostate cancer with radiation (after it came back) can be done safely and how side effects affect people. It also checks whether this approach is practical to carry out, especially for urinary side effects and comfort during the process.
This trial studies whether using special computer software and expert input can safely give a second round of radiation to treat cancers that have come back or spread in a limited way. It aims to offer a chance for cure when standard treatments may not work.
This study tests a more personalized way to plan “re-irradiation,” meaning giving radiation again in an area that was already treated before. It aims to better calculate organ risk to reduce harmful side effects while treating cancer.
This trial tests a focused radiation treatment for patients who have developed a new cancer in the same breast after previous breast-conserving therapy. The goal is to safely treat the cancer while minimizing radiation to surrounding healthy tissue.
This trial tests giving a higher dose of radiation to people whose rectal cancer has come back in the pelvis after surgery and cannot be removed. It aims to see if more radiation can help control the tumor when surgery is not an option.
Hear when a new Radiotherapy Side Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.